Mullerian agenesis: An update

Obstetrics and Gynecology

Volumn 90, Issue 2, 1997, Pages 307-312

  Lindenman, Elizabeth ^a   Shepard, Marguerite K ^a   Pescovitz, Ora Hirsch ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR; MUELLERIAN INHIBITING FACTOR; GLYCOPROTEIN; GROWTH INHIBITOR; MULLERIAN INHIBITING HORMONE; MULLERIAN-INHIBITING HORMONE; TESTIS PEPTIDE HORMONE;

EMBRYO DEVELOPMENT; FEMALE; GENE MUTATION; HUMAN; MUELLERIAN DUCT; NOTE; PRIORITY JOURNAL; RECEPTOR GENE; ROKITANSKY SYNDROME; SURGICAL TECHNIQUE; VAGINA APLASIA; VAGINA RECONSTRUCTION; CONGENITAL MALFORMATION; GENETICS; MALE; MUTATION; REVIEW; SEX DIFFERENTIATION; SYNDROME; VAGINA;

ABNORMALITIES; FEMALE; GLYCOPROTEINS; GROWTH INHIBITORS; HUMANS; MALE; MULLERIAN DUCTS; MUTATION; SEX DIFFERENTIATION; SYNDROME; TESTICULAR HORMONES; VAGINA;

EID: 0030611695     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00256-1     Document Type: Note

References (21)

1. Gustafson M, Donahoe P. Mullerian-inhibiting substance: Critical roles in sexual differentiation. In: Wachtels S, ed. Molecular genetics of sex determination. 1st ed. San Diego: Academic Press, 1994:457-502.
2. Josso N, Imbeaud S, Picard J, Cote R. The gene for anti-mullerian hormone. In: Wachtel S, ed. Molecular genetics of sex determination. 1st ed. San Diego: Academic Press, 1994:439-55.
3. Jones K. Rokitansky sequence. In: Schafler A, ed. Smith's recognizable patterns of human malformation. 4th ed. Philadelphia: WB Saunders, 1988:570-1.
4. MacLaughlin D, Levin R, Catlin E, Taylor L, Preffer F, Donahoe P. Identification of mullerian inhibiting substance specific binding in human cell lines. Horm Metab Res 1992;24:570-5.
5. Lee M, Donahoe P. Mullerian inhibiting substance: A gonadal hormone with multiple functions. Endocr Rev 1993;14:152-64.
6. Lee M, Cate R, Donahoe P, Waneck G. Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for mullerian inhibiting substance. Endocrinology 1992;130:847-53.
7. MacLaughlin D, Hudson P, Graciano A, Kenneally MK, Ragin RC, Manganaro TF, et al. Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain. Endocrinology 1992;131:291-6.
8. di Clemente N, Wilson C, Faure E, Boussin L, Carmillo P, Tizard R, et al. Cloning, expression, and alternative splicing of the receptor for anti-mullerian hormone. Mol Endocrinol 1994;8:1006-20.
9. Carre-Eusebe D, Imbeaud S, Harbison M, New M, Josso N, Picard J. Variants of the anti-mullerian hormone gene in a compound heterozygote with the persistent mullerian duct syndrome and his family. Hum Genet 1992;90:389-94.
10. Lee M, Donahoe P, Hasegawa T, Silverman B, Crist GB, Best S, et al. Mullerian inhibiting substance in humans: Normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996;81:571-6.
11. Behringer R. The in vivo roles of mullerian inhibiting substance. Curr Top Dev Biol 1994;29:171-87.
12. Hirobe S, He W, Gustafson M, MacLaughlin D, Donohoe P. Mullerian inhibiting substance gene expression in the cycling rat ovary correlates with recruited or graafian follicle selection. Biol Reprod 1994;50:1238-43.
13. Grootegoed J, Baarends W, Themmen A. Welcome to the family: The anti-mullerian hormone receptor. Mol Cell Endocrinol 1994; 100:29-34.
14. Wang T, Donohoe P, Zervos A. Specific interaction of type I receptors of the TGF-B family with the immunophilin FKBP-12. Science 1994;265:674-6.
15. Imbeaud S, Faure E, Lamarre I, Mattéi MG, di Clemente N, Tizard R, et al. Insensitivity to anti-mullerian hormone due to a mutation in the human anti-mullerian hormone receptor. Nat Genet 1995; 11:382-8.
16. Meyers-Wallen V, Lee M, Manganaro T, Kuroda T, MacLaughlin D, Donahoe P. Mullerian inhibiting substance is present in embryonic testes of dogs with persistent mullerian duct syndrome. Biol Reprod 1993;48:1410-8.
17. Rock J, Reeves L, Retto H, Baramki T, Zacur H, Jones H. Success following vaginal creation for mullerian agenesis. Fertil Steril 1983;39:809-13.
18. Ingram J. The bicycle seat stool in the treatment of vaginal agenesis and stenosis: A preliminary report. Am J Obstet Gynecol 1981;140: 867-71.
19. Linde T. Surgery for anomalies of the mullerian ducts. In: Thompson J, Rock J, eds. Operative gynecology. 7th ed. Philadelphia: JB Lippincott, 1992:614-9.
20. Jackson N, Rosenblatt P. Use of interceed absorbable adhesion barrier for vaginoplasty. Obstet Gynecol 1994;84:1048-50.
21. Fedele L, Busacca M, Candiani M, Vignali M. Laparoscopic creation of a neovagina in Mayer-Rokitansky-Kuster-Hauser syndrome by modification of Vecchietti's operation. Am J Obstet Gynecol 1994;171:268-9.